Cardiometabolic Medicine

The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia.  These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.  

Our Tweetorials

Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.

Update on CTEPH

1) Welcome to a new #accredited #tweetorial about an important complication of #pulmonaryembolism (#PE): chronic thromboembolic pulmonary...

@Cardiomet_CE on Twitter

Your only source for ACCREDITED SoMe-delivered 

serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!

On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME.  Programs are presented by expert faculty in engaging and fully interactive format.  Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.

Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.

cardio-metFollow

Your only source for JOINT-ACCREDITED SoMe-delivered, serialized professional cardiometabolic education. Physicians, nurses, pharmacists--come one, come all!

cardio-met
Retweet on Twittercardio-met Retweeted
SABOURETCardioSABOURETCardiologist@SABOURETCardio·
12h

Nice to see ⁦@GiuseppeGalati_⁩ at #EASCongress . First #CardioTwitter publication with my friend ⁦@AngoulvantD⁩ in 3d. One of the first #CardioDiabetology articles with #Interplay. Now in FREE access

2
Reply on Twitter 1530098238140841986Retweet on Twitter 15300982381408419865Like on Twitter 153009823814084198617Twitter 1530098238140841986
Retweet on Twittercardio-met Retweeted
JTLLERGOJavier Torres@JTLLERGO·
13h

⚠️ Impact of dapagliflozin treatment on renal function and diuretics use in acute heart failure: a pilot study‼️

@Open_HeartBMJ @secardiologia @CardioRenalSEC @almucastro01 @SACardiologia @clinica_sec @yulnunezvill @MartaCoboMarcos @rdelaespriella

https://openheart.bmj.com/content/9/1/e001936?utm_source=alert&utm_medium=email&utm_campaign=oh&utm_content=latest&utm_term=27052022

4
Reply on Twitter 1530087172379901958Retweet on Twitter 153008717237990195838Like on Twitter 153008717237990195866Twitter 1530087172379901958
Load More...